Success for Glaxo’s 3D mark for purple asthma inhaler
Glaxo has prevailed on appeal in these long-running invalidity proceedings, with the General Court annulling a EUIPO decision invalidating Glaxo’s 3D mark for the shape of an inhaler.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the WTR experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10